Molecular and biophysical requirements for B cell receptor-dependent enhancement of dengue virus infection
Journal of Virology · 2026
DOI: 10.1128/jvi.02216-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Gaby Madrigal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, Vermont, USA. Hauptthemen laut MEDLINE: Dengue Virus, Dengue, B-Lymphocytes, Antibody-Dependent Enhancement. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Dengue virus (DENV) is the causative agent of dengue, a mosquito-borne disease that represents a significant and growing public health burden around the world. A unique pathophysiological feature of dengue is immune-mediated enhancement, wherein preexisting immunity elicited by a primary infection can enhance the severity of a subsequent infection by a heterologous DENV serotype. A leading mechanistic explanation for this phenomenon is antibody-dependent enhancement (ADE), where sub-neutralizing concentrations of DENV-specific IgG antibodies facilitate the entry of DENV into FcγR-expressing cells. Accordingly, this model posits that phagocytic mononuclear cells are the primary reservoir of DENV. However, multiple independent groups have shown that B cells are the largest reservoir of virally infected cells in circulation during acute dengue, representing a disconnect in our understanding of immune-mediated DENV tropism. In response to this persistent knowledge gap, our team has previously identified a novel mechanism of immune-mediated enhancement we have termed B cell receptor (BCR)-dependent enhancement (BDE) of DENV infection. In this study, we show that DENV infection of DENV-reactive B cells is highly sensitive to BCR/DENV envelope (E) protein interactions. DENV entry into this subset of B cells is dynamin-mediated, requires proximal BCR signaling, and involves localization to late endosomes. Finally, we show that immortalized DENV-reactive B cells are productively infected by live DENV, capable of supporting active viral replication of all four serotypes. We propose that BDE provides an additional layer of pathogen-specific immune-mediated infection risk that complements existing models of ADE and offers additional insight into potential mechanisms of DENV immunopathogenesis. IMPORTANCE This study provides mechanistic insight into the process of B cell receptor (BCR)-dependent enhancement of dengue virus (DENV) infection. Immune-mediated enhancement of infection is a cornerstone of dengue immunopathogenesis and is most often attributed to antibody-dependent enhancement (ADE). BCR-dependent enhancement of DENV infection is an alternative and complementary mechanism for immune-mediated enhancement that addresses several persistent knowledge gaps in the dengue field and may offer mechanistic insight into why some people progress to severe dengue after infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.
- Cellular and Molecular Biomedical Sciences Graduate Program, University of Vermont, Burlington, Vermont, USA.
- Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, New York, USA.
- Vaccine Testing Center, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.
- Translational Global Infectious Diseases Research Center, University of Vermont, Burlington, Vermont, USA.
- Global Health Institute, State University of New York Upstate Medical University, Syracuse, New York, USA.
ORCID-Profile: Gaby Madrigal, Chad Gebo, Sean A Diehl, Adam T Waickman
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of General Medical Sciences
Zitieren
APA
Madrigal, G., Gebo, C., McElvany, B. D., Symeonides, M., Diehl, S. A., & Waickman, A. T. (2026). Molecular and biophysical requirements for B cell receptor-dependent enhancement of dengue virus infection. Journal of Virology. https://doi.org/10.1128/jvi.02216-25
Vancouver
Madrigal G, Gebo C, McElvany BD, Symeonides M, Diehl SA, Waickman AT. Molecular and biophysical requirements for B cell receptor-dependent enhancement of dengue virus infection. Journal of Virology. 2026. doi:10.1128/jvi.02216-25
BibTeX
@article{Madrigal2026,
author = {Madrigal, Gaby and Gebo, Chad and McElvany, Benjamin D and Symeonides, Menelaos and Diehl, Sean A and Waickman, Adam T},
title = {Molecular and biophysical requirements for B cell receptor-dependent enhancement of dengue virus infection},
journal = {Journal of Virology},
year = {2026},
doi = {10.1128/jvi.02216-25}
}
EUVIMED